RESPIRATORY MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2264868, encodeId=ea41226486801, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：垃圾期刊投稿拖好久润色后最后拒收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adc79728035, createdName=ms8000000073549382, createdTime=Tue May 13 17:03:51 CST 2025, time=2025-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263739, encodeId=6fb42263e3990, content=With editor 是还没有送外审吧 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfb02040938, createdName=1581e9a617m, createdTime=Tue May 06 17:40:14 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=)]

2025-05-13 ms8000000073549382 来自广东省

审稿速度:12.0 | 投稿命中率:25.0
经验分享：垃圾期刊投稿拖好久润色后最后拒收

13 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2264868, encodeId=ea41226486801, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：垃圾期刊投稿拖好久润色后最后拒收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adc79728035, createdName=ms8000000073549382, createdTime=Tue May 13 17:03:51 CST 2025, time=2025-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263739, encodeId=6fb42263e3990, content=With editor 是还没有送外审吧 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfb02040938, createdName=1581e9a617m, createdTime=Tue May 06 17:40:14 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=)]

2025-05-06 1581e9a617m 来自北京

With editor 是还没有送外审吧
谢谢

12 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2264868, encodeId=ea41226486801, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：垃圾期刊投稿拖好久润色后最后拒收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adc79728035, createdName=ms8000000073549382, createdTime=Tue May 13 17:03:51 CST 2025, time=2025-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263739, encodeId=6fb42263e3990, content=With editor 是还没有送外审吧 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfb02040938, createdName=1581e9a617m, createdTime=Tue May 06 17:40:14 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=)]

2023-12-06 ms9000001233094927 来自浙江省

11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。

173 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2264868, encodeId=ea41226486801, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：垃圾期刊投稿拖好久润色后最后拒收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adc79728035, createdName=ms8000000073549382, createdTime=Tue May 13 17:03:51 CST 2025, time=2025-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263739, encodeId=6fb42263e3990, content=With editor 是还没有送外审吧 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfb02040938, createdName=1581e9a617m, createdTime=Tue May 06 17:40:14 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=)]

2023-11-07 嘻嘻号来自江苏省

审稿速度:1.0 | 投稿命中率:5.0
经验分享：未送审临床预测模型有外部验证，投稿7天后被拒

141 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2264868, encodeId=ea41226486801, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：垃圾期刊投稿拖好久润色后最后拒收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adc79728035, createdName=ms8000000073549382, createdTime=Tue May 13 17:03:51 CST 2025, time=2025-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263739, encodeId=6fb42263e3990, content=With editor 是还没有送外审吧 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfb02040938, createdName=1581e9a617m, createdTime=Tue May 06 17:40:14 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=)]

2021-04-21 想不出网名

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：公共卫生;统计;大数据
经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。

171 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2264868, encodeId=ea41226486801, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：垃圾期刊投稿拖好久润色后最后拒收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adc79728035, createdName=ms8000000073549382, createdTime=Tue May 13 17:03:51 CST 2025, time=2025-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263739, encodeId=6fb42263e3990, content=With editor 是还没有送外审吧 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfb02040938, createdName=1581e9a617m, createdTime=Tue May 06 17:40:14 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=)]

2022-04-17 ms5000001799088561

现在期刊要求加载不进去了么？想投稿进不去要求

152 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2264868, encodeId=ea41226486801, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：垃圾期刊投稿拖好久润色后最后拒收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adc79728035, createdName=ms8000000073549382, createdTime=Tue May 13 17:03:51 CST 2025, time=2025-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263739, encodeId=6fb42263e3990, content=With editor 是还没有送外审吧 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfb02040938, createdName=1581e9a617m, createdTime=Tue May 06 17:40:14 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=)]

2021-12-29 衣谷

文章题目有没有撰写模板？

163 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2264868, encodeId=ea41226486801, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：垃圾期刊投稿拖好久润色后最后拒收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adc79728035, createdName=ms8000000073549382, createdTime=Tue May 13 17:03:51 CST 2025, time=2025-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263739, encodeId=6fb42263e3990, content=With editor 是还没有送外审吧 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfb02040938, createdName=1581e9a617m, createdTime=Tue May 06 17:40:14 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=)]

2021-12-27 Mia

什么样的题目能让审稿人眼前一亮？

149 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2264868, encodeId=ea41226486801, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：垃圾期刊投稿拖好久润色后最后拒收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adc79728035, createdName=ms8000000073549382, createdTime=Tue May 13 17:03:51 CST 2025, time=2025-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263739, encodeId=6fb42263e3990, content=With editor 是还没有送外审吧 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfb02040938, createdName=1581e9a617m, createdTime=Tue May 06 17:40:14 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=)]

2020-09-13 ms8381557919440379

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：过敏;COPD;ILD
经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。

252 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2264868, encodeId=ea41226486801, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：垃圾期刊投稿拖好久润色后最后拒收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adc79728035, createdName=ms8000000073549382, createdTime=Tue May 13 17:03:51 CST 2025, time=2025-05-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263739, encodeId=6fb42263e3990, content=With editor 是还没有送外审吧 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfb02040938, createdName=1581e9a617m, createdTime=Tue May 06 17:40:14 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=)]

2020-07-28 ms1000000620964775

审稿速度:2.0
经验分享：一个多月直接被拒了，没有给任何理由

236 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务